- Home
- / Cologuard
Cologuard
Revenue
$1 B
Y, 2021
Cologuard Summary
Company Summary
- Overview
- Cologuard is a DNA-based colorectal cancer screening test provided by Exact Sciences. It analyzes stool samples for 10 DNA markers, as well as blood in the stool (hemoglobin).
- Type
- Subsidiary
- Status
- Active
- Founded
- 2014
- Website
- https://www.cologuard.com/
- Cybersecurity rating
Table of Contents
Cologuard Financials
Summary Financials
- Revenue (Y, 2021)
- $1.0B
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026